(b) In order to avoid interference, only the first‐episode AIS patients were enrolled; thus, lnc‐ITSN1‐2 expression and its correlation with disease severity, inflammation, and RFS in patients with relapsed AIS should be studied further. This evidence concerns the gene ITSN1 and androgen insensitivity syndrome.